On November 8, 2023, the U.S. Food and Drug Administration (FDA) issued a guidance document titled Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing. It emphasized the FDA's preparedness to accept factory registration and product listing submissions by the original statutory deadline of December 29, 2023, mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The FDA plans to launch the electronic submission portal-Cosmetics Direct-along with supporting documents and paper submission forms in early December 2023 to facilitate the process.
While companies capable of meeting the original deadline are still encouraged to proceed, the FDA, in response to the industry's feedback requesting more preparation time, has opted to extend the enforcement deadline for cosmetic facility registration and product listing requirements by an extra six months. This extension allows cosmetic stakeholders to complete the processes of facility registration and product listing no later than July 1, 2024.
Facility Registration and Product Listing Obligations under MoCRA
Requirements and Original Deadline
All entities engaged in the manufacture or processing of cosmetic products for the U.S. market, regardless of their geographical location, must register their facilities with the FDA and renew such registration biennially. Foreign facilities, in particular, shall designate a U.S. Agent during registration for effective communication with the FDA.
Facilities in operation when MoCRA was enacted must complete registration with the FDA by December 29, 2023. New facilities commencing cosmetic production afterwards must be registered within 60 days after they begin manufacturing or processing cosmetics, or within 60 days after December 29, 2023, whichever is later.
Responsible person for cosmetics intended for distribution in the U.S., namely, manufacturer, packer and distributor of a cosmetic product whose name appears on the label, must list each marketed cosmetic product with the FDA. The product listing shall be renewed annually. Notably, a single listing submission can encompass multiple products with identical formulations or minor variations in color, fragrance, flavor, and/or quantity.
Existing cosmetic products, which were already on the market prior to MoCRA’s enactment, must be listed with the FDA no later than December 29, 2023. For new products introduced after MoCRA's enactment, the listing with the FDA should be done within 120 days from the date of their initial launch on the market.
Notes: There are exemptions for certain companies under specific circumstances: